FDA Inspection
Siegfried Hameln GmbHSiegfried Hameln GmbH – FDA Inspection, Apr 24, 2018
Record Details
This FDA Inspection record concerns Siegfried Hameln GmbH, with an inspection on April 24, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · e042aba9-c4b7-422c-b3eb-1a852022bb80
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1050123
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Siegfried Hameln GmbH
5| Date | Classification | Office | Project area |
|---|---|---|---|
| September 1, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 1, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 25, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 14, 2012 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 9, 2009 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Siegfried Hameln GmbH
- FDA Inspection 1203347 - 2022-09-01
- FDA Inspection 987428 - 2016-07-01
- FDA Inspection 887446 - 2014-07-25
- FDA Inspection 786813 - 2012-06-14
- FDA Inspection 637807 - 2009-11-09
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.